Europe Will Lose Out On Medical Innovation If Draft EU Reforms Pass, Novo Nordisk CEO Says

Europe will lose out to countries like the U.S. and Japan on new medical research, trials and treatments unless draft rules reforming the European pharmaceutical landscape change, the CEO of Danish

Related Keywords

Boston ,Massachusetts ,United States ,Brussel ,Bruxelles Capitale ,Belgium ,Japan ,Denmark ,Brussels ,Danish ,Stella Kyriakides ,Novo Jorgensen ,Novo Lars Jorgensen ,Eu Health ,European Union ,European Commission ,Novo Nordisk ,Reuters ,Lars Jorgensen ,Commissioner Stella Kyriakides ,Inflation Reduction Act ,Business , ,